Patient Group   Number         Mean Age     Mean Follow-up                               (years)      (months)Pseudotumour...
Pseudotumour Group      Non-Pseudotumour GroupNumber of implants          8                       22Gender (female: male) ...
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Young-Min Kwon; Kappa Delta Award, 2011
Upcoming SlideShare
Loading in...5
×

Young-Min Kwon; Kappa Delta Award, 2011

1,767

Published on

Presentation by Dr Young-Min Kwon for the 2011 Kappa Delta Award.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
1,767
On Slideshare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
90
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Young-Min Kwon; Kappa Delta Award, 2011

  1. 1. Patient Group Number Mean Age Mean Follow-up (years) (months)Pseudotumour 10 (1M:9F) 56 (45-62) 65 (19-79)Non- 60 (30M:30F) 55 (40-69) 61 (13-88)PseudotumourControl 22 (13M:9F) 55 (50-58) Pre-operative
  2. 2. Pseudotumour Group Non-Pseudotumour GroupNumber of implants 8 22Gender (female: male) 8:0 13:9Mean Age (years) 52 (range 39 - 65) 54 (range 45 - 70)Mean Time in vivo (years) 3.6 (range 1.1 – 6.6) 2.3 (range 1.0 – 5.8)Mean Femoral component 47 (range 42 - 50) 49 (range 44 - 54)size (mm)Implant Type BHR (5) BHR (18) Conserve Plus (2) Conserve Plus (4) Cormet (1)
  1. A particular slide catching your eye?

    Clipping is a handy way to collect important slides you want to go back to later.

×